
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5272470
[patent_doc_number] => 20090076246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE'
[patent_app_type] => utility
[patent_app_number] => 12/198007
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15512
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076246.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198007 | Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure | Aug 24, 2008 | Issued |
Array
(
[id] => 63390
[patent_doc_number] => 07759066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Molecule associating with intracellular C-terminal domain of receptor'
[patent_app_type] => utility
[patent_app_number] => 12/191213
[patent_app_country] => US
[patent_app_date] => 2008-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 18957
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12191213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/191213 | Molecule associating with intracellular C-terminal domain of receptor | Aug 12, 2008 | Issued |
Array
(
[id] => 9574976
[patent_doc_number] => 08765388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'VHZ for diagnosis and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/672902
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 21
[patent_no_of_words] => 35004
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672902
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672902 | VHZ for diagnosis and treatment of cancer | Aug 7, 2008 | Issued |
Array
(
[id] => 5521957
[patent_doc_number] => 20090029938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING DISEASE INCLUDING INFLAMMATORY CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/187433
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19246
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12187433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/187433 | Oligonucleotide compositions and methods for treating disease including inflammatory conditions | Aug 6, 2008 | Issued |
Array
(
[id] => 5975926
[patent_doc_number] => 20110070240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'METHODS OF TREATING B-CELL CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/672088
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17887
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070240.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672088
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672088 | Methods of treating B-cell cancers | Aug 5, 2008 | Issued |
Array
(
[id] => 5361603
[patent_doc_number] => 20090036397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA'
[patent_app_type] => utility
[patent_app_number] => 12/185182
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12799
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185182 | RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA | Aug 3, 2008 | Abandoned |
Array
(
[id] => 5361602
[patent_doc_number] => 20090036396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/184351
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12948
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036396.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184351 | RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS | Jul 31, 2008 | Abandoned |
Array
(
[id] => 6577629
[patent_doc_number] => 20100273856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'SCREENING OF MICRO-RNA CLUSTER INHIBITOR POOLS'
[patent_app_type] => utility
[patent_app_number] => 12/670363
[patent_app_country] => US
[patent_app_date] => 2008-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14043
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670363 | Screening of micro-RNA cluster inhibitor pools | Jul 20, 2008 | Issued |
Array
(
[id] => 5284874
[patent_doc_number] => 20090098549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'SELEX AND PHOTOSELEX'
[patent_app_type] => utility
[patent_app_number] => 12/175388
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 23867
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098549.pdf
[firstpage_image] =>[orig_patent_app_number] => 12175388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/175388 | Selex and photoSELEX | Jul 16, 2008 | Issued |
Array
(
[id] => 4515926
[patent_doc_number] => 07910723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'IG20 splice variants therapeutics for cancer'
[patent_app_type] => utility
[patent_app_number] => 12/174296
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 24993
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910723.pdf
[firstpage_image] =>[orig_patent_app_number] => 12174296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/174296 | IG20 splice variants therapeutics for cancer | Jul 15, 2008 | Issued |
Array
(
[id] => 9971171
[patent_doc_number] => 09018180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'CD44 splice variants in neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 12/668563
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 22105
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668563 | CD44 splice variants in neurodegenerative diseases | Jul 9, 2008 | Issued |
Array
(
[id] => 5422952
[patent_doc_number] => 20090149407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER\'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/170290
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 52899
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12170290
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/170290 | RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA) | Jul 8, 2008 | Issued |
Array
(
[id] => 5336741
[patent_doc_number] => 20090053205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/168641
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 14110
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12168641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/168641 | Stabilized immune modulatory RNA (SIMRA) compounds | Jul 6, 2008 | Issued |
Array
(
[id] => 6454634
[patent_doc_number] => 20100189725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'P53 MODULATOR AND CANCER TARGET'
[patent_app_type] => utility
[patent_app_number] => 12/667314
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22720
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667314
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667314 | P53 modulator and cancer target | Jul 2, 2008 | Issued |
Array
(
[id] => 5564656
[patent_doc_number] => 20090137509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/167045
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 60333
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137509.pdf
[firstpage_image] =>[orig_patent_app_number] => 12167045
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/167045 | RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Jul 1, 2008 | Abandoned |
Array
(
[id] => 6342742
[patent_doc_number] => 20100329993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 12/666983
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8925
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0329/20100329993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666983
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666983 | METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE | Jun 26, 2008 | Abandoned |
Array
(
[id] => 5521485
[patent_doc_number] => 20090029466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/143027
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31430
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143027 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | Jun 19, 2008 | Abandoned |
Array
(
[id] => 5521955
[patent_doc_number] => 20090029936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/143024
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 31372
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029936.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143024
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143024 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | Jun 19, 2008 | Abandoned |
Array
(
[id] => 5361060
[patent_doc_number] => 20090035854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/143006
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31414
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143006 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | Jun 19, 2008 | Abandoned |
Array
(
[id] => 5361867
[patent_doc_number] => 20090036661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/143009
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31386
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143009 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | Jun 19, 2008 | Abandoned |